SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

1 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2023.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 122K shares of 56M outstanding shares and own 0.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (10.4M shares), VANGUARD GROUP INC (6.21M shares), ARMISTICE CAPITAL, LLC (4.65M shares), MACQUARIE GROUP LTD (2.74M shares), DIMENSIONAL FUND ADVISORS LP (2.46M shares), STATE STREET CORP (2.06M shares), Polar Capital Holdings Plc (1.94M shares), Stephens Investment Management Group LLC (1.9M shares), LOOMIS SAYLES & CO L P (1.64M shares), and RENAISSANCE TECHNOLOGIES LLC (1.38M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.